Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
763.140.1%
QQQ
716.510.03%
BTC/USD
78450.840.2161%
DIA
524.880.15%
GLD
402.810.13%
TLT
81.680.06%

bioAffinity Technologies Inc (BIAF) Stock Price, Quote, News & History

BIAFNASDAQ
Trade with Public
Trade with Public
$10.50
1.5717.58%
At close: Sep 9, 5:00 PM EST
$11.00
0.504.76%
After Hours: 7:59 PM EST
PRO
Why Is It Moving?™:bioAffinity Technologies shares are trading higher after the company announ...
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

bioAffinity Technologies (BIAF) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$10.90
Close
$10.50
Volume / Avg.
10.46M / 2.31M
Day Range
$10.09 - $12.32
52 Wk Range
4.56 - 202.50
Market Cap
$6.61M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
57
Short Interest
32.89%
Days to Cover
1

Recent bioAffinity Technologies Inc News

Dow Tumbles 450 Points; US Small Business Sentiment Declines In August

U.S. stocks fell Tuesday, led by a 450-point Dow drop; health care slid while energy rose. NFIB optimism weakened, oil and copper gained.
Avi Kapoor

Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket

iSpecimen surged 27.9% premarket on a $4.5M Foldlab AI asset deal; CEA Industries led gainers, while Focus Universal plunged 51.2%.
Avi Kapoor

BioAffinity Technologies Stock Skyrockets Wednesday: What's Happening?

bioAffinity Technologies is surging Wednesday as traders digest recent commercial expansion news alongside tight low-float trading dynamics.
Henry Khederian

Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings

U.S. stocks edged higher, led by the Dow and materials. Ollie’s beat EPS estimates; biotech and AI shares surged, while Tscan plunged 26%.
Avi Kapoor

BioAffinity Advances Noninvasive CyPath Lung Test For Post-Treatment Monitoring

bioAffinity stock trades higher as it advances its CyPath Lung test for post-treatment lung cancer surveillance.
Vandana Singh

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-11.47M
Investing Cash Flow (TTM)
-91.99K
Financing Cash Flow (TTM)
13.19M
Free Cash Flow (TTM)
-11.56M
Capital Expenditure (TTM)
-91.99K
Net Change in Cash (TTM)
1.63M

Valuation Metrics

Enterprise Value
$5.37M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
0.46
PB Ratio (TTM)
1.69
Earnings Yield % (TTM)
-12.75%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$6.27

Company Debt

Total Debt
$59.03K
LT Debt
$36.47K
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$248.17K
Total Cash
$2.43M
Debt to Equity
0.38
Issuance of Debt (TTM)
-$248.17K
Repayment of Debt (TTM)
-$248.17K

Key Statistics

Open
$10.90
Close
$10.50
Volume / Avg.
10.46M / 2.31M
Day Range
$10.09 - $12.32
52 Wk Range
4.56 - 202.50
Market Cap
$6.61M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
57
Short Interest
32.89%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy bioAffinity Technologies (BIAF) stock?

A

You can purchase shares of bioAffinity Technologies (NASDAQ:BIAF) through any online brokerage.

View our list of the best stock brokerages

Q

Who are bioAffinity Technologies (BIAF) competitors?

Q

What is the forecast, or price target, for bioAffinity Technologies (BIAF) stock?

A

There is no analysis for bioAffinity Technologies to provide a consensus price target.

Q

What is the current price for bioAffinity Technologies (BIAF)?

A

The stock price for bioAffinity Technologies (NASDAQ: BIAF) is $11 last updated September 9, 2026 at 7:59 PM EDT.

Q

Does bioAffinity Technologies (BIAF) pay a dividend?

A

There are no upcoming dividends for bioAffinity Technologies.

Q

When is bioAffinity Technologies (NASDAQ:BIAF) reporting earnings?

A

bioAffinity Technologies does not have any upcoming earnings scheduled.

Q

Is bioAffinity Technologies (BIAF) going to split?

A

There is no upcoming split for bioAffinity Technologies.

Q

What sector and industry does bioAffinity Technologies (BIAF) operate in?

A

bioAffinity Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved